Arie Perry
Arie Perry
Professor and Director of Neuropathology, UCSF
Verified email at
Cited by
Cited by
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131, 803-820, 2016
The 2021 WHO classification of tumors of the central nervous system: a summary
DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ...
Neuro-oncology 23 (8), 1231-1251, 2021
WHO classification of tumours of the central nervous system
DN Louis
(No Title), 2016
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
JE Eckel-Passow, DH Lachance, AM Molinaro, KM Walsh, PA Decker, ...
New England Journal of Medicine 372 (26), 2499-2508, 2015
Primary brain tumours in adults
S Lapointe, A Perry, NA Butowski
The Lancet 392 (10145), 432-446, 2018
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith, A Perry, TJ Borell, HK Lee, J O’Fallon, SM Hosek, D Kimmel, ...
Journal of Clinical Oncology 18 (3), 636-636, 2000
New brain tumor entities emerge from molecular classification of CNS-PNETs
D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...
Cell 164 (5), 1060-1072, 2016
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition
M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ...
Cancer cell 25 (3), 393-405, 2014
Meningioma grading: an analysis of histologic parameters
A Perry, SL Stafford, BW Scheithauer, VJ Suman, CM Lohse
The American journal of surgical pathology 21 (12), 1455-1465, 1997
Neurofibromatosis type 1
DH Gutmann, RE Ferner, RH Listernick, BR Korf, PL Wolters, KJ Johnson
Nature Reviews Disease Primers 3 (1), 1-17, 2017
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
DJ Brat, K Aldape, H Colman, EC Holland, DN Louis, RB Jenkins, ...
Acta neuropathologica 136, 805-810, 2018
“Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications
A Perry, BW Scheithauer, SL Stafford, CM Lohse, PC Wollan
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
FJ Rodriguez, AL Folpe, C Giannini, A Perry
Acta neuropathologica 123, 295-319, 2012
A Perry
Practical surgical neuropathology: a diagnostic approach, 259-298, 2018
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121, 381-396, 2011
Histological classification and molecular genetics of meningiomas
MJ Riemenschneider, A Perry, G Reifenberger
The Lancet Neurology 5 (12), 1045-1054, 2006
Notch1 and notch2 have opposite effects on embryonal brain tumor growth
X Fan, I Mikolaenko, I Elhassan, XZ Ni, Y Wang, D Ball, DJ Brat, A Perry, ...
Cancer research 64 (21), 7787-7793, 2004
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ...
Neuro-oncology 18 (4), 557-564, 2015
The system can't perform the operation now. Try again later.
Articles 1–20